NCT05513716 Molecular Characterisation of Colorectal Cancer Peritoneal Metastases
| NCT ID | NCT05513716 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Christie NHS Foundation Trust |
| Condition | Colorectal Cancer Metastatic |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-02-04 |
| Primary Completion | 2025-07-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2024-02-04 with a primary completion date of 2025-07-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project aims to characterise the tumour cell and tumour microenvironment of colorectal cancer peritoneal metastases, understand molecular changes leading to colorectal peritoneal metastasis, identify potential biomarkers and novel treatment strategies.
Eligibility Criteria
Participants are eligible to be included in the study only if all of the following criteria apply: 1. Patients ≥ 18 years old who have been diagnosed with colorectal cancer and have colorectal peritoneal metastases, 2. have had cytoreductive surgery at the Christie 3. have availability of archival tumour tissue (paired CRC and CRPM) Exclusion Criteria: * None
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05513716 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Cancer Metastatic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05513716 currently recruiting?
Yes, NCT05513716 is actively recruiting participants. Contact the research team at removed_due_to_spam@email.com for enrollment information.
Where is the NCT05513716 trial being conducted?
This trial is being conducted at Manchester, United Kingdom.
Who is sponsoring the NCT05513716 clinical trial?
NCT05513716 is sponsored by The Christie NHS Foundation Trust. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.